GBCS OTC
Selectis Health, Inc.
1W: +0.0%
1M: +0.3%
3M: +10.0%
YTD: +156.9%
1Y: +154.7%
3Y: +20.6%
5Y: -0.3%
$5.73
-0.02 (-0.26%)
Weekly Expected Move ±1.5%
$6
$6
$6
$6
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$39M
+7.4% ▲
5Y CAGR: +41.6%
Gross Profit
$9M
+68.9% ▲
5Y CAGR: +17.0%
Operating Income
-$3M
+69.5% ▲
Net Income
-$2M
+39.0% ▲
EPS (Diluted)
$-0.80
+38.9% ▲
EBITDA
$1M
+116.4% ▲
5Y CAGR: -13.6%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $21M | $29M | $41M | $37M | $39M |
| YoY Growth | +202.0% | +39.9% | +38.6% | -9.4% | +7.4% |
| Cost of Revenue | $13M | $21M | $30M | $31M | $30M |
| Gross Profit | $8M | $8M | $11M | $5M | $9M |
| Gross Margin | 36.0% | 26.7% | 26.5% | 14.7% | 23.1% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2M | $7M | $9M | $13M | $9M |
| Operating Expenses | $3M | $6M | $8M | $13M | $12M |
| Operating Income | $3M | -$729K | -$287K | -$9M | -$3M |
| Operating Margin | 16.1% | -2.5% | -0.7% | -24.4% | -6.9% |
| Interest Expense | $2M | $2M | $2M | $2M | $2M |
| Income Before Tax | $3M | -$2M | -$2M | -$4M | -$2M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | $3M | -$2M | -$2M | -$4M | -$2M |
| Net Margin | 14.1% | -7.7% | -5.9% | -10.8% | -6.1% |
| EPS (Diluted) | $0.30 | $-0.82 | $-0.79 | $-1.31 | $-0.80 |
| EBITDA | $5M | $1M | $2M | -$7M | $1M |
| Shares Outstanding | 3M | 3M | 3M | 3M | 3M |